Free Trial

BGM Group (BGM) Competitors

$9.76 -0.56 (-5.43%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$10.04 +0.28 (+2.82%)
As of 07:39 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BGM vs. ZLAB, PTCT, MRUS, ACAD, ACLX, SWTX, AAPG, RNA, RARE, and PTGX

Should you be buying BGM Group stock or one of its competitors? The main competitors of BGM Group include Zai Lab (ZLAB), PTC Therapeutics (PTCT), Merus (MRUS), ACADIA Pharmaceuticals (ACAD), Arcellx (ACLX), SpringWorks Therapeutics (SWTX), Ascentage Pharma Group International (AAPG), Avidity Biosciences (RNA), Ultragenyx Pharmaceutical (RARE), and Protagonist Therapeutics (PTGX). These companies are all part of the "pharmaceutical products" industry.

BGM Group vs. Its Competitors

BGM Group (NASDAQ:BGM) and Zai Lab (NASDAQ:ZLAB) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

Zai Lab has a consensus price target of $54.28, indicating a potential upside of 52.93%. Given Zai Lab's stronger consensus rating and higher probable upside, analysts clearly believe Zai Lab is more favorable than BGM Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BGM Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Zai Lab
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

41.7% of Zai Lab shares are held by institutional investors. 58.7% of BGM Group shares are held by company insiders. Comparatively, 5.0% of Zai Lab shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

BGM Group has a net margin of 0.00% compared to Zai Lab's net margin of -60.26%. BGM Group's return on equity of 0.00% beat Zai Lab's return on equity.

Company Net Margins Return on Equity Return on Assets
BGM GroupN/A N/A N/A
Zai Lab -60.26%-33.35%-23.28%

BGM Group has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500. Comparatively, Zai Lab has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500.

In the previous week, Zai Lab had 27 more articles in the media than BGM Group. MarketBeat recorded 29 mentions for Zai Lab and 2 mentions for BGM Group. BGM Group's average media sentiment score of 0.81 beat Zai Lab's score of 0.32 indicating that BGM Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BGM Group
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Zai Lab
10 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
5 Negative mention(s)
1 Very Negative mention(s)
Neutral

BGM Group has higher earnings, but lower revenue than Zai Lab.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BGM Group$25.10M37.80-$1.44MN/AN/A
Zai Lab$398.99M9.88-$257.10M-$2.49-14.25

Summary

BGM Group beats Zai Lab on 8 of the 14 factors compared between the two stocks.

Get BGM Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for BGM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BGM vs. The Competition

MetricBGM GroupMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.00B$2.88B$5.54B$8.87B
Dividend YieldN/A2.64%5.39%4.10%
P/E RatioN/A21.3126.2319.90
Price / Sales37.80278.47413.23113.66
Price / CashN/A41.4736.1356.90
Price / Book1.337.518.045.38
Net Income-$1.44M-$55.05M$3.15B$248.50M
7 Day Performance-23.87%2.07%1.44%2.04%
1 Month Performance-27.86%4.84%3.62%4.84%
1 Year PerformanceN/A5.37%34.68%20.23%

BGM Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BGM
BGM Group
N/A$9.76
-5.4%
N/AN/A$1.00B$25.10M0.00298
ZLAB
Zai Lab
3.4171 of 5 stars
$35.23
+0.7%
$54.28
+54.1%
+104.3%$3.91B$398.99M-14.121,869Analyst Forecast
Insider Trade
Analyst Revision
Gap Up
PTCT
PTC Therapeutics
4.4282 of 5 stars
$48.95
+0.2%
$65.00
+32.8%
+61.7%$3.88B$806.78M7.521,410Analyst Revision
MRUS
Merus
1.8468 of 5 stars
$52.63
+0.0%
$84.64
+60.8%
+0.5%$3.66B$36.13M-12.9637
ACAD
ACADIA Pharmaceuticals
4.6956 of 5 stars
$21.47
-0.5%
$27.88
+29.8%
+34.1%$3.60B$957.80M15.69510
ACLX
Arcellx
2.8121 of 5 stars
$64.36
-2.3%
$111.23
+72.8%
+24.6%$3.55B$107.94M-21.5680Positive News
SWTX
SpringWorks Therapeutics
1.558 of 5 stars
$46.99
+0.0%
$52.57
+11.9%
N/A$3.54B$191.59M-13.78230
AAPG
Ascentage Pharma Group International
N/A$39.51
+0.3%
N/AN/A$3.44B$134.35M0.00600Positive News
RNA
Avidity Biosciences
2.1929 of 5 stars
$28.34
-0.2%
$65.59
+131.5%
-24.3%$3.40B$10.90M-9.41190
RARE
Ultragenyx Pharmaceutical
3.9662 of 5 stars
$35.58
-2.2%
$87.00
+144.5%
-3.7%$3.36B$560.23M-6.051,294
PTGX
Protagonist Therapeutics
1.8837 of 5 stars
$53.26
-3.6%
$66.10
+24.1%
+46.5%$3.30B$434.43M71.09120

Related Companies and Tools


This page (NASDAQ:BGM) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners